Yuan Xu
Director/Board Member bij AKERO THERAPEUTICS, INC.
Vermogen: - $ op 31-03-2024
Profiel
Yuan J.
Xu is an Independent Director at Fate Therapeutics, Xilio Therapeutics, and Akero Therapeutics.
Previously, Xu served as the Chief Executive Officer & Director at Legend Biotech Corp., General Manager & Vice President-Biologics at Gilead Sciences, Senior Vice President at Merck & Co., and Vice President at Novartis AG.
Xu holds a doctorate from the University of Maryland and an undergraduate degree from Nanjing University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
LEGEND BIOTECH CORP.
-.--% | 08-06-2020 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Yuan Xu
Bedrijven | Functie | Begin |
---|---|---|
AKERO THERAPEUTICS, INC. | Director/Board Member | 22-04-2021 |
FATE THERAPEUTICS, INC. | Director/Board Member | 03-08-2021 |
XILIO THERAPEUTICS, INC. | Director/Board Member | 04-01-2022 |
Eerdere bekende functies van Yuan Xu
Bedrijven | Functie | Einde |
---|---|---|
LEGEND BIOTECH CORPORATION | Chief Executive Officer | 01-08-2020 |
MERCK & CO., INC. | Corporate Officer/Principal | 01-08-2017 |
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01-08-2015 |
NOVARTIS AG | Corporate Officer/Principal | 01-01-2014 |
Opleiding van Yuan Xu
University of Maryland | Doctorate Degree |
Nanjing University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 7 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
MERCK & CO., INC. | Health Technology |
NOVARTIS AG | Health Technology |
FATE THERAPEUTICS, INC. | Health Technology |
LEGEND BIOTECH CORPORATION | Health Technology |
XILIO THERAPEUTICS, INC. | Health Technology |
AKERO THERAPEUTICS, INC. | Health Technology |